Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

FERRARO, Donatella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.773
EU - Europa 2.533
AS - Asia 2.237
SA - Sud America 409
AF - Africa 75
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 11.037
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.697
SG - Singapore 850
CN - Cina 781
IT - Italia 694
FI - Finlandia 376
BR - Brasile 344
UA - Ucraina 292
HK - Hong Kong 250
RU - Federazione Russa 249
DE - Germania 211
IE - Irlanda 151
GB - Regno Unito 126
PL - Polonia 108
VN - Vietnam 95
SE - Svezia 89
FR - Francia 79
IN - India 54
CA - Canada 43
BE - Belgio 33
AT - Austria 26
KR - Corea 25
AR - Argentina 23
BD - Bangladesh 23
MX - Messico 23
TR - Turchia 22
NL - Olanda 21
RO - Romania 21
UZ - Uzbekistan 19
CI - Costa d'Avorio 17
IQ - Iraq 16
IR - Iran 15
JP - Giappone 15
ES - Italia 14
EC - Ecuador 12
ZA - Sudafrica 12
VE - Venezuela 10
CZ - Repubblica Ceca 9
CO - Colombia 8
ID - Indonesia 8
KE - Kenya 8
SA - Arabia Saudita 8
MA - Marocco 7
PK - Pakistan 7
CH - Svizzera 6
DZ - Algeria 6
PY - Paraguay 6
LT - Lituania 5
SN - Senegal 5
TN - Tunisia 5
AM - Armenia 4
AU - Australia 4
EG - Egitto 4
KG - Kirghizistan 4
NP - Nepal 4
PH - Filippine 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
BY - Bielorussia 3
CL - Cile 3
GR - Grecia 3
HN - Honduras 3
IL - Israele 3
JO - Giordania 3
KZ - Kazakistan 3
LB - Libano 3
MY - Malesia 3
TW - Taiwan 3
AL - Albania 2
AZ - Azerbaigian 2
CG - Congo 2
EU - Europa 2
GE - Georgia 2
HR - Croazia 2
LV - Lettonia 2
NG - Nigeria 2
NO - Norvegia 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BJ - Benin 1
BW - Botswana 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GH - Ghana 1
GM - Gambi 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
LK - Sri Lanka 1
MC - Monaco 1
MD - Moldavia 1
ML - Mali 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
OM - Oman 1
Totale 11.030
Salva come PNG Salva come JPEG
Città #
Ashburn 734
Fairfield 714
Singapore 478
Chandler 452
Woodbridge 389
Wilmington 290
Houston 279
Ann Arbor 275
Seattle 260
Hong Kong 242
Cambridge 235
Palermo 174
Jacksonville 154
Dublin 150
Beijing 138
Medford 137
Des Moines 129
Nanjing 113
Zgierz 90
Altamura 88
Los Angeles 85
Princeton 83
Moscow 75
Dallas 64
Lawrence 63
Boardman 59
New York 54
San Diego 50
The Dalles 49
Hefei 46
Shenyang 43
Tulsa 41
Buffalo 39
Ho Chi Minh City 37
Milan 34
Brussels 32
London 31
Dearborn 29
Nanchang 29
Hanoi 28
Frankfurt am Main 27
Santa Clara 27
Changsha 25
Jinan 24
Rome 24
Hebei 22
Ottawa 22
São Paulo 21
Jiaxing 20
Phoenix 17
Zhengzhou 17
Abidjan 16
Helsinki 16
Tianjin 16
Ludwigshafen am Rhein 15
Munich 15
Ningbo 15
Saint Petersburg 15
Kumar 14
Tashkent 14
Tokyo 14
Chicago 13
Columbus 12
Guangzhou 12
Izmir 12
Rio de Janeiro 12
San Paolo di Civitate 12
Turku 12
Hangzhou 11
Norwalk 11
Nuremberg 11
Orem 11
Seongnam 11
Seoul 11
Orange 10
Tehran 10
Vienna 10
Atlanta 9
Goiânia 9
Salvador 9
Warsaw 9
Belo Horizonte 8
Brooklyn 8
Chennai 8
Curitiba 8
Johannesburg 8
Mexico City 8
Taizhou 8
Auburn Hills 7
Brasília 7
Montreal 7
Nairobi 7
Roubaix 7
San Francisco 7
San Mateo 7
Santo André 7
Ancona 6
Boston 6
Brno 6
Campinas 6
Totale 7.241
Salva come PNG Salva come JPEG
Nome #
HCV genotypes in Sicily: is there any evidence of a shift? 279
HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals 265
Hepatitis B virus reactivation and alemtuzumab therapy 240
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. 229
HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin 226
Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of transcription-mediated amplification assay 221
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension 220
Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: a randomized controlled trial 194
Phylogenetic Reconstruction of HCV Genotype 1b Dissemination in a Small City Centre: The Camporeale Model 183
Predictors of Hepatitis B Surface Antigen Titers two decades after vaccination in a cohort of students and post-graduates of the Medical School at the University of Palermo, Italy 179
Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension:a randomized controlled trial 178
Fibrosis Evaluation by Transient Elastography in Patients With Long-Term Sustained HCV Clearance 176
Binding of flunitrazepam to differentiating neurons cultured in a chemically defined, hormone-supplemented medium 174
Hepatitis B virus reactivation and alemtuzumab therapy 172
Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C. 169
Endemic hepatitis C virus infection in a Sicilian town: Further evidence for iatrogenic transmission 168
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C. 167
Phylogenetic Analysis of isolates from new cases of HBV infection in Southern Italy. 166
Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitis 164
Liver disease in chelated transfusion-dependent thalassemics: the role of iron and chronic hepatitis C 163
Role of IL-28B and inosine triphosphatase polymorphisms in efficacy and safety of Peg-Interferon and ribavirin in chronic hepatitis C compensated cirrhosis with and without oesophageal varices. 163
Characterization of measles virus strains circulating in Southern Italy (Palermo area, Sicily) between 2010 and 2011 163
Antibodies Responses to SARS-CoV-2 in a Large Cohort of Vaccinated Subjects and Seropositive Patients 160
Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction 151
RUOLO DELL’INFEZIONE OCCULTA DA HBV NEL PAZIENTE IMMUNOCOMPROMESSO 149
HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy 149
The impact of sustained virological response on clinical outcomes in compensated HCV cirrhosis: a prospective cohort study 149
Impact of HBV genotypes A and D genetic variability on infection evolution 147
Rat CNS neurons are not yet programmed to shorten their chromatin repeat length at the end of fetal neurogenesis 146
Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. 145
Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study) 145
Genotyping of Legionella pneumophila serogroup 1 strains isolated in Northern Sicily, Italy. 139
An Analysis of the Neutralizing Antibodies against the Main SARS-CoV-2 Variants in Healthcare Workers (HCWs) Vaccinated against or Infected by SARS-CoV-2 133
Triiodothyronine‐Induced Shortening of Chromatin Repeat Length in Neurons Cultured in a Chemically Denned Medium 132
Virus-related insulin resistance in HCV genotype 1 chronic hepatitis C : a major disease modifier 131
Valutazione della clearance di HCV-RNA sotto trattamento antivirale con Transcription-Mediated Amplification (TMA) 131
Age and Cytokine Gene Variants Modulate the Immunogenicity and Protective Effect of SARS-CoV-2 mRNA-Based Vaccination 129
VARIABILITY OF THE HBV POL GENE REVERSE-TRANSCRIPTASE DOMAIN IN VIRAL ISOLATES FROM UNTREATED AND LAMIVUDINE-RESISTANT CHRONIC HEPATITIS B PATIENTS 128
A rs4374383 Single Nucleotide Polymorphisms of MERTK gene is linked to a higher likelihood of hepatocellular carcinoma in patients with HCV cirrhosis 127
The impact of sustained virological response on clinical outcome in compensated HCV cirrhosis: a prospective cohort study 126
Inhibition of glial proliferation in vitro by serum from patients with multiple sclerosis 125
HCV CLEARANCE AFTER PEG IFN PLUS RBV IMPROVES THE COURSE OF HCV CIRRHOSIS REGARDLESS OF PORTAL HYPERTENSION 125
EVALUATING THE RISK OF HEPATITIS B REACTIVATION IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: IS THE SERUM HEPATITIS B PROFILE RELIABLE? 123
HCV-1b intra-subtype variability: Impact on genetic barrier to protease inhibitors 122
Infezione occulta da HBV in pazienti con malattie linfoproliferative in trattamento chemioterapico 119
Bayesian coalescent inference of hepatitis C virus introduction from molecular sequences: the Camporeale model 119
HCV genotypes in western Sicily: any evidence for a shift? 117
No detection of occult HBV-DNA in patients with various rheumatic diseases treated with anti-TNF agents: a two-year prospective study. 117
LIVER RELATED EVENTS AND SURVIVAL IN PATIENTS WITH COMPENSATED HCV CIRRHOSIS: THE ROLE OF SUSTAINED VIROLOGICAL RESPONSE TO PEG-IFN BASED THERAPY AND PORTAL HYPERTENSION 116
Neutralizing Antibodies Response against SARS-CoV-2 Variants of Concern Elicited by Prior Infection or mRNA BNT162b2 Vaccination 116
IL-10 and TNF-α polymorphisms and the recovery from HCV infection 112
Infezione occulta da HBV in pazienti con malattie oncoematologiche 111
Triiodothyronine accelerates the synthesis of Synapsin I in developing neurons from fetal rat brain cultured in a synthetic medium 111
FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT 111
PEG-interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response 110
The effect of antiviral therapy on clinical outcome of HCV cirrhosis with portal hypertension: a prospective cohort study. 109
FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT 109
Valutazione della clearance di HCV-RNA sotto trattamentio antivirale con Transcription-Mediated Amplification (TMA) 108
PEG_interferon plus Ribavirin in compensated HCV cirrhosis with portal hypertension: the role of rapid and early virological response in predicting the sustained virological response 108
Epidemiologia molecolare dell'infezione da HCV in un Comune Siciliano 107
Cinetica della risposta virologica e della comparsa di mutanti virali in pazienti con malattia cronica di fegato HBV-correlatain terapia con adefovir 104
Risk of disease decompensation and HCC in patients with HCV cirrhosis non responders to PEG IFN plus RBV 104
The risk of hepatocellular carcinoma in HBV cirrhosis is affected by polymorphisms of the MERTK gene 101
LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C 100
Evaluation of the diagnostic performances of two commercially available assays for the detection of enteric adenovirus antigens 97
Phylodynamic Analysis and Implication of HCV Genotype 4 Variability on Antiviral Drug Response and T-Cell Recognition 95
Infezione occulta da HBV nel paziente immunocompromesso.studio dell'eterogeneità virale 94
Riattivazione dell'infezione occulta da HBV nel paziente immunocompromesso:studio dell'eterogeneità virale 94
LOW VITAMIN D SERUM LEVEL IS RELATED TO RAPID, EARLY AND SUSTAINED VIROLOGICAL RESPONSE TO IFN-BASED THERAPY IN GENOTYPE 1 CHRONIC HEPATITIS C 91
RIATTIVAZIONE DELL’INFEZIONE OCCULTA DA HBV NEL PAZIENTE IMMUNOCOMPROMESSO: STUDIO DELLA ETEROGENEITÀ VIRALE 90
Serological status for TORCH in women of childbearing age: a decade-long surveillance (2012-2022) in Italy 88
Differing kinetics of anti-spike protein IgGs and neutralizing antibodies against SARS-CoV-2 after Comirnaty (BNT162b2) immunization 87
High rate of spontaneous viral clearance in patients with iatrogenic acute hepatitis C 86
Heterogeneity of HVR-1 quasispecies is predictive of early but not sustained virological response in genotype 1b-infected patients undergoing combined treatment with PEG- or STD-IFN plus RBV 85
HBsAg quantification in HBeAg negative cirrhosis on nucleoside/nucleotide analogue (NA) and risk of development of HCC 85
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. 84
ISDR pattern and evolution in patients with chronic hepatitis C treated with standard or PEG-IFN plus ribavirin 84
Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C 80
PEG-INTERFERON PLUS RIBAVIRIN IN COMPENSATED HCV CIRRHOSIS WITH PORTAL HYPERTENSION: THE ROLE OF RAPID AND EARLY VIROLOGICAL RESPONSE IN PREDICTING THE SUSTAINED VIROLOGICAL RESPONSE 80
PHYLOGENETIC ANALYSIS OF HBV INFECTION IN SICILY: IS THE EPIDEMIOLOGY CHANGING? 76
Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the EGG18 study 76
Viral Sequence Analysis of Occult HBV Infection and Its Reactivation in Immunosuppressed Patients 73
INFEZIONE OCCULTA DA HBV NEL PAZIENTE IMMUNOCOMPROMESSO: STUDIO DELLA ETEROGENEITA’ VIRALE 72
Phylogenetic analysis in the clinical risk management of an outbreak of hepatitis C virus infection among transfused thalassaemia patients in Italy 71
Do not forget mpox! 69
Atypical case of monkeypox with multiple bacterial skin superinfection 65
Monkeypox proctitis treated with doxycycline in an HIV MSM returning to Italy from France 56
PEG-INTERFERON PLUS RIBAVIRIN IN HCV CIRRHOSIS WITH PORTAL HYPERTENSION: ROLE OF VIRAL AND HOST FACTORS IN HCV CLEARANCE 52
Liver follicular helper T-cells in chronic hepatitis C 50
Post-COVID-19 Epidemiology of Viral Infections in Adults Hospitalized with Acute Respiratory Syndromes in Palermo, South of Italy 20
Neutralizing Antibody Response to SARS-CoV-2 Variants After Two mRNA COVID-19 Vaccine Doses in a Cohort of Patients with Inflammatory Bowel Disease from a Southern Italy Tertiary Hospital 6
Multiple nodules and pustules in a traveler 6
Totale 11.492
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.060
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.060
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021586 0 0 0 0 0 43 56 61 153 82 75 116
2021/2022949 36 204 45 36 24 34 40 51 113 131 53 182
2022/20231.362 129 286 23 126 148 217 95 85 141 9 65 38
2023/2024561 35 65 44 71 61 114 37 23 14 16 10 71
2024/20251.646 26 97 56 156 58 62 129 109 136 202 238 377
2025/20262.165 445 181 287 414 583 255 0 0 0 0 0 0
Totale 11.492